Your browser does not support JavaScript!
Logo de Labiotech.eu

Labiotech.eu Source d'actualité

Une actualité de Labiotech.eu a été ajouté(e)
Hier à 08:34
GSK Acne Deal Heralds Growing Interest in Skin Microbiome
This week, the Paris-based Eligo Bioscience became one of a growing number of biotechs to land a big pharma deal focused on the skin microbiome, receiving up to €185M from GlaxoSmithKline (GSK) as...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours
How Much Control Should Investors Have Over Your Biotech Company?
The post How Much Control Should Investors Have Over Your Biotech Company? appeared first on Labiotech.eu....
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours
Labiotech.eu Gets a Facelift for 2021
Happy New Year, and welcome to the new Labiotech.eu! We decided to surprise you with a fresh look to start 2021. In the last couple of months, we’ve been working hard to create a better website...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 6 jours
Ethics, Investment, and What Comes Next in Gene-Editing Technologies
As next-generation gene-editing technologies become increasingly popular, biotech industry stakeholders carry the responsibility to ensure the ethical deployment of these tools through mindful...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 6 jours
How the Vaccine Industry and Biotechs Can Accelerate Pandemic Responses
The global Covid-19 pandemic has forced us to put our lives on hold, and a vaccine is the most likely route back to normality. Vaccine development is in the limelight, and our need for one has led us...
www.labiotech.eu
Charger plus d'actualités

Informations juridiques
SIREN / SIRET - DE Labiotech

Adresse
Berlin Berlin DE Allemagne